Radiation therapy and radiofrequency ablation (RFA) developer RITA Medical Systems of Mountain View, CA, said that the Japanese Ministry of Health, Labor, and Welfare (MHLW) has approved and established reimbursement for the treatment of liver cancer with radiofrequency ablation (RFA).
The company said the approval becomes effective on April 1, 2004, and sets reimbursement at 136,000 yen ($1,200 U.S.). The company markets the only MHLW-approved radiofrequency ablation device in Japan, according to RITA Medical.
By AuntMinnie.com staff writers
March 11, 2004
Related Reading
RITA claims reimbursement momentum for RFA, March 4, 2004
Uecker hired as RITA CTO, January 13, 2004
RITA slows losses in Q3, October 23, 2003
RITA names Pedroff as VP, September 18, 2003
RITA taps Soto, September 11, 2003
Copyright © 2004 AuntMinnie.com
